| EASL clinical practice guidelines: management of hepatocellular carcinoma PR Galle, A Forner, JM Llovet, V Mazzaferro, F Piscaglia, JL Raoul, ... Journal of hepatology 69 (1), 182-236, 2018 | 7286 | 2018 |
| Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial M Kudo, RS Finn, S Qin, KH Han, K Ikeda, F Piscaglia, A Baron, JW Park, ... The Lancet 391 (10126), 1163-1173, 2018 | 4926 | 2018 |
| EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology J Bamber, D Cosgrove, CF Dietrich, J Fromageau, J Bojunga, F Calliada, ... Ultraschall in der Medizin-European Journal of Ultrasound 34 (02), 169-184, 2013 | 1580 | 2013 |
| Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012 M Claudon, CF Dietrich, BI Choi, DO Cosgrove, M Kudo, CP Nolsøe, ... Ultraschall in der Medizin-European journal of ultrasound 34 (01), 11-29, 2013 | 1561 | 2013 |
| The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications F Piscaglia, C Nolsøe, CF Dietrich, DO Cosgrove, OH Gilja, MB Nielsen, ... Ultraschall in der Medizin-European Journal of Ultrasound 33 (01), 33-59, 2012 | 1486 | 2012 |
| EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications D Cosgrove, F Piscaglia, J Bamber, J Bojunga, JM Correas, OH Gilja, ... Ultraschall in der Medizin-European Journal of Ultrasound 34 (03), 238-253, 2013 | 1348 | 2013 |
| Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008 M Claudon, D Cosgrove, T Albrecht, L Bolondi, M Bosio, F Calliada, ... Ultraschall in der Medizin-European Journal of Ultrasound 29 (01), 28-44, 2008 | 1269 | 2008 |
| EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version) CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ... Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017 | 1155 | 2017 |
| The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version) PS Sidhu, V Cantisani, CF Dietrich, OH Gilja, A Saftoiu, E Bartels, ... Ultraschall in der Medizin-European journal of ultrasound 39 (02), e2-e44, 2018 | 1101 | 2018 |
| Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis L Bolondi, S Sofia, S Siringo, S Gaiani, A Casali, G Zironi, F Piscaglia, ... Gut 48 (2), 251-259, 2001 | 871 | 2001 |
| Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions L Bolondi, A Burroughs, JF Dufour, PR Galle, V Mazzaferro, F Piscaglia, ... Seminars in liver disease 32 (04), 348-359, 2012 | 764 | 2012 |
| The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations F Piscaglia, L Bolondi Ultrasound in medicine & biology 32 (9), 1369-1375, 2006 | 683 | 2006 |
| Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization JL Raoul, B Sangro, A Forner, V Mazzaferro, F Piscaglia, L Bolondi, ... Cancer treatment reviews 37 (3), 212-220, 2011 | 677 | 2011 |
| Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study F Piscaglia, G Svegliati‐Baroni, A Barchetti, A Pecorelli, S Marinelli, ... Hepatology 63 (3), 827-838, 2016 | 614 | 2016 |
| Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma L Bolondi, S Gaiani, N Celli, R Golfieri, WF Grigioni, S Leoni, AM Venturi, ... Hepatology 42 (1), 27-34, 2005 | 562 | 2005 |
| Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2020–WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS CF Dietrich, CP Nolsøe, RG Barr, A Berzigotti, PN Burns, V Cantisani, ... Ultraschall in der Medizin-European Journal of Ultrasound 41 (05), 562-585, 2020 | 520 | 2020 |
| Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma A Cucchetti, F Piscaglia, M Cescon, A Colecchia, G Ercolani, L Bolondi, ... Journal of hepatology 59 (2), 300-307, 2013 | 459 | 2013 |
| Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria M Ravaioli, GL Grazi, F Piscaglia, F Trevisani, M Cescon, G Ercolani, ... American Journal of Transplantation 8 (12), 2547-2557, 2008 | 442 | 2008 |
| Field‐practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ... Hepatology 54 (6), 2055-2063, 2011 | 425 | 2011 |
| An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion CF Dietrich, MA Averkiou, JM Correas, N Lassau, E Leen, F Piscaglia Ultraschall in der Medizin-European Journal of Ultrasound 33 (04), 344-351, 2012 | 422 | 2012 |
Christoph F. DietrichProfessor of Medicine, Kliniken Hirslanden Bern, Beau Site, Salem und Permanenceכתובת אימייל מאומתת בדומיין hirslanden.ch